Overview
- A team at Edith Cowan University reported in a May 2026 Alzheimer’s & Dementia paper that common variants in the aquaporin‑4 (AQP4) gene interact with sleep habits to predict early brain atrophy and cognitive change.
- The study combined genotypes for 13 AQP4 variants with self‑reported sleep measures, serial brain imaging and cognition in about 351 cognitively unimpaired people who had brain amyloid accumulation.
- Researchers found that some AQP4 variants were linked directly to regional brain volume and cognition and that the same variant could be protective or harmful depending on sleep duration, sleep latency or overall sleep quality.
- Key examples included carriers of certain variants showing faster grey‑matter loss when they reported short sleep and other variants magnifying ventricular enlargement when sleep quality was poor.
- Authors say the results justify genetics‑informed, sleep‑focused clinical trials but they stress limits of the work—self‑reported sleep, modest and Australian‑only sample, and the need for replication—so they do not recommend routine AQP4 genetic testing now.